The human SLC2A4 promoter drives expression of human OGT in the adipose tissue and cardiac and skeletal muscle. Five transgenic lines were generated with most studies using lines 15, 26, and 32. This is a representative record where unspecified lines among Tg15, Tg18, Tg23, and Tg32 were used in determining phenotype.